Stevanato Group (NYSE:STVN) Announces Quarterly Earnings Results, Misses Estimates By $0.01 EPS

Stevanato Group (NYSE:STVN) posted its earnings results on Friday. The company reported €0.11 EPS for the quarter, missing the consensus estimate of €0.12 by (€0.01), Briefing.com reports. The business had revenue of €273.57 million during the quarter. Stevanato Group had a net margin of 11.83% and a return on equity of 10.44%. Stevanato Group’s revenue was up 6.6% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.10 earnings per share.

Stevanato Group Stock Performance

NYSE STVN traded up €0.20 during trading hours on Friday, hitting €18.23. The company had a trading volume of 655,785 shares, compared to its average volume of 671,758. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.26 and a current ratio of 1.76. Stevanato Group has a 1-year low of €12.89 and a 1-year high of €28.00. The company has a market cap of $5.52 billion, a PE ratio of 31.43, a price-to-earnings-growth ratio of 1.70 and a beta of 0.75. The business has a 50 day moving average of €15.16 and a 200-day moving average of €18.75.

Analyst Upgrades and Downgrades

STVN has been the topic of several recent analyst reports. Citigroup dropped their target price on Stevanato Group from $32.00 to $26.00 and set a “buy” rating on the stock in a report on Thursday, March 5th. Jefferies Financial Group set a $17.50 target price on Stevanato Group in a report on Tuesday, February 10th. Wall Street Zen lowered Stevanato Group from a “buy” rating to a “hold” rating in a report on Saturday, February 14th. Weiss Ratings lowered Stevanato Group from a “hold (c-)” rating to a “sell (d+)” rating in a report on Wednesday, March 11th. Finally, KeyCorp decreased their price objective on shares of Stevanato Group from $37.00 to $32.00 and set an “overweight” rating for the company in a research note on Thursday, March 5th. Three investment analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold”.

Hedge Funds Weigh In On Stevanato Group

Several large investors have recently bought and sold shares of STVN. GW&K Investment Management LLC boosted its stake in shares of Stevanato Group by 76.2% during the fourth quarter. GW&K Investment Management LLC now owns 2,440 shares of the company’s stock worth $49,000 after buying an additional 1,055 shares during the period. State of Wyoming boosted its stake in shares of Stevanato Group by 39,216.7% during the second quarter. State of Wyoming now owns 2,359 shares of the company’s stock worth $58,000 after buying an additional 2,353 shares during the period. Quantbot Technologies LP acquired a new stake in shares of Stevanato Group during the third quarter worth about $68,000. Tower Research Capital LLC TRC boosted its stake in shares of Stevanato Group by 1,268.7% during the second quarter. Tower Research Capital LLC TRC now owns 4,585 shares of the company’s stock worth $112,000 after buying an additional 4,250 shares during the period. Finally, Walleye Capital LLC acquired a new stake in shares of Stevanato Group during the fourth quarter worth about $214,000.

About Stevanato Group

Stevanato Group is a global provider of primary packaging solutions and related services for the pharmaceutical and biotech industries. The company specializes in the design, development and manufacturing of glass drug containers such as vials, cartridges and pre-fillable syringes, as well as advanced inspection systems and assembly equipment. Its integrated offerings cover the entire packaging supply chain, from component production to bespoke filling lines and serialization technology.

In addition to its core glass business, Stevanato Group delivers engineering services and process validation support to pharmaceutical customers.